These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24368413)

  • 1. Stem-cell-based gene therapy for HIV infection.
    Zhen A; Kitchen S
    Viruses; 2013 Dec; 6(1):1-12. PubMed ID: 24368413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
    Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
    Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus and the hematopoietic repertoire: implications for gene therapy.
    Panoskaltsis N; Abboud CN
    Front Biosci; 1999 May; 4():D457-67. PubMed ID: 10228094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell-based therapies for HIV/AIDS.
    Pernet O; Yadav SS; An DS
    Adv Drug Deliv Rev; 2016 Aug; 103():187-201. PubMed ID: 27151309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
    Walker JE; Chen RX; McGee J; Nacey C; Pollard RB; Abedi M; Bauer G; Nolta JA; Anderson JS
    J Virol; 2012 May; 86(10):5719-29. PubMed ID: 22398281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody.
    Joseph A; Zheng JH; Chen K; Dutta M; Chen C; Stiegler G; Kunert R; Follenzi A; Goldstein H
    J Virol; 2010 Jul; 84(13):6645-53. PubMed ID: 20410262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell transplantation in the context of HIV--how can we cure HIV infection?
    Bauer G; Anderson JS
    Expert Rev Clin Immunol; 2014 Jan; 10(1):107-16. PubMed ID: 24308835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the BLT humanized mouse as a stem cell based gene therapy tumor model.
    Vatakis DN; Bristol GC; Kim SG; Levin B; Liu W; Radu CG; Kitchen SG; Zack JA
    J Vis Exp; 2012 Dec; (70):e4181. PubMed ID: 23271478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 as a natural and modulated target for inhibition of HIV.
    Burke BP; Boyd MP; Impey H; Breton LR; Bartlett JS; Symonds GP; Hütter G
    Viruses; 2013 Dec; 6(1):54-68. PubMed ID: 24381033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J; Banda N; Lee NS; Rossi J; Akkina R
    Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
    Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
    J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential mechanisms for cell-based gene therapy to treat HIV/AIDS.
    Herrera-Carrillo E; Berkhout B
    Expert Opin Ther Targets; 2015 Feb; 19(2):245-63. PubMed ID: 25388088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practice.
    DiGiusto DL; Stan R; Krishnan A; Li H; Rossi JJ; Zaia JA
    Viruses; 2013 Nov; 5(11):2898-919. PubMed ID: 24284880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 immunopathogenesis in humanized mouse models.
    Zhang L; Su L
    Cell Mol Immunol; 2012 May; 9(3):237-44. PubMed ID: 22504952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer.
    Carrillo MA; Zhen A; Kitchen SG
    Front Immunol; 2018; 9():746. PubMed ID: 29755454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
    Lai Y
    Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering hematopoietic stem cells toward a functional cure of human immunodeficiency virus infection.
    Wang J; Holmes MC
    Cytotherapy; 2016 Nov; 18(11):1370-1381. PubMed ID: 27745602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells.
    Kitchen SG; Levin BR; Bristol G; Rezek V; Kim S; Aguilera-Sandoval C; Balamurugan A; Yang OO; Zack JA
    PLoS Pathog; 2012; 8(4):e1002649. PubMed ID: 22511873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell-based approaches to treating HIV infection.
    Kitchen SG; Zack JA
    Curr Opin HIV AIDS; 2011 Jan; 6(1):68-73. PubMed ID: 21242896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.